Is ProKidney Corp. overvalued?

ProKidney Corp. (PROK) — key valuation metrics and fundamentals.

No verdict

Price

$1.33

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$447.2M

Dividend yield

0.0%

Return on equity

12.3%

Sector

Healthcare

Fair value compares PROK's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks